Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study.

van Zyl LT, Lespérance F, Frasure-Smith N, Malinin AI, Atar D, Laliberté MA, Serebruany VL.

J Thromb Thrombolysis. 2009 Jan;27(1):48-56. doi: 10.1007/s11239-007-0189-3. Epub 2008 Jan 11.

PMID:
18188512
2.

Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy.

Serebruany VL, Glassman AH, Malinin AI, Nemeroff CB, Musselman DL, van Zyl LT, Finkel MS, Krishnan KR, Gaffney M, Harrison W, Califf RM, O'Connor CM; Sertraline AntiDepressant Heart Attack Randomized Trial Study Group.

Circulation. 2003 Aug 26;108(8):939-44. Epub 2003 Aug 11. Erratum in: Circulation. 2003 Dec 23;108(25):3165.

3.

Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.

Lespérance F, Frasure-Smith N, Koszycki D, Laliberté MA, van Zyl LT, Baker B, Swenson JR, Ghatavi K, Abramson BL, Dorian P, Guertin MC; CREATE Investigators.

JAMA. 2007 Jan 24;297(4):367-79. Erratum in: JAMA. 2007 Jul 4;298(1):40.

PMID:
17244833
4.

Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.

Klinkhardt U, Bauersachs R, Adams J, Graff J, Lindhoff-Last E, Harder S.

Clin Pharmacol Ther. 2003 Mar;73(3):232-41.

PMID:
12621388
5.

Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.

Perneby C, Wallén NH, Hofman-Bang C, Tornvall P, Ivert T, Li N, Hjemdahl P.

Thromb Haemost. 2007 Dec;98(6):1316-22.

PMID:
18064330
6.

Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.

Tetik S, Ak K, Isbir S, Eksioglu-Demiralp E, Arsan S, Iqbal O, Yardimci T.

Clin Appl Thromb Hemost. 2010 Apr;16(2):189-98. doi: 10.1177/1076029609344980. Epub 2009 Aug 23.

PMID:
19703819
7.

Decreased platelet 5-hydroxytryptamin (5-HT) levels: a response to antidepressants.

Li X, Fan Y, Xiao S, Peng S, Dong X, Zheng X, Liu CC, Li H, Xiao Z.

J Affect Disord. 2015 Nov 15;187:84-90. doi: 10.1016/j.jad.2015.08.025. Epub 2015 Aug 21.

PMID:
26321259
8.

Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression.

Serebruany VL, Suckow RF, Cooper TB, O'Connor CM, Malinin AI, Krishnan KR, van Zyl LT, Lekht V, Glassman AH; Sertraline Antidepressant Heart Attack Randomized Trial.

Am J Psychiatry. 2005 Jun;162(6):1165-70.

PMID:
15932816
9.

Differential impact of selective serotonin reuptake inhibitors on platelet response to clopidogrel: a randomized, double-blind, crossover trial.

Hirsh-Rokach B, Spectre G, Shai E, Lotan A, Ritter A, Al-Aieshy F, Malmström RE, Varon D, Alcalai R.

Pharmacotherapy. 2015 Feb;35(2):140-7. doi: 10.1002/phar.1542.

PMID:
25689244
10.

Randomized controlled trial of aspirin and clopidogrel versus aspirin and placebo on markers of smooth muscle proliferation before and after peripheral angioplasty.

Wilson AM, Brittenden J, Bachoo P, Ford I, Nixon GF.

J Vasc Surg. 2009 Oct;50(4):861-9. doi: 10.1016/j.jvs.2009.06.017.

11.

Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention.

Muller O, Hamilos M, Bartunek J, Ulrichts H, Mangiacapra F, Holz JB, Ntalianis A, Trana C, Dierickx K, Vercruysse K, De Bruyne B, Wijns W, Barbato E.

Am J Cardiol. 2010 Feb 1;105(3):333-8. doi: 10.1016/j.amjcard.2009.09.033. Epub 2009 Dec 22.

PMID:
20102944
12.

Prothrombotic platelet phenotype in major depression: downregulation by antidepressant treatment.

Lopez-Vilchez I, Serra-Millas M, Navarro V, Rosa Hernandez M, Villalta J, Diaz-Ricart M, Gasto C, Escolar G, Galan AM.

J Affect Disord. 2014 Apr;159:39-45. doi: 10.1016/j.jad.2014.02.022. Epub 2014 Feb 20.

PMID:
24679387
13.

A randomized controlled trial of platelet activity before and after cessation of clopidogrel therapy in patients with stable cardiovascular disease.

Ford I, Scott NW, Herd V, Mitchell LR, Williams DJ, Brittenden J.

J Am Coll Cardiol. 2014 Jan 28;63(3):233-9. doi: 10.1016/j.jacc.2013.10.018. Epub 2013 Nov 6.

14.

Design and rationale for a randomized, controlled trial of interpersonal psychotherapy and citalopram for depression in coronary artery disease (CREATE).

Frasure-Smith N, Koszycki D, Swenson JR, Baker B, van Zyl LT, Laliberté MA, Abramson BL, Lambert J, Gravel G, Lespérance F.

Psychosom Med. 2006 Jan-Feb;68(1):87-93. Erratum in: Psychosom Med. 2007 Mar-Apr;69(2):216.

PMID:
16449416
15.

Changes in platelet P-selectin and in plasma C-reactive protein in acute atherosclerotic ischemic stroke treated with a loading dose of clopidogrel.

Cha JK, Jeong MH, Lee KM, Bae HR, Lim YJ, Park KW, Cheon SM.

J Thromb Thrombolysis. 2002 Oct;14(2):145-50.

PMID:
12714834
16.

The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.

Jagroop IA, Matsagas MI, Geroulakos G, Mikhailidis DP.

Platelets. 2004 Mar;15(2):117-25.

PMID:
15154604
17.

Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment.

Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Sabaté M, Jimenez-Quevedo P, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Macaya C.

Diabetes. 2005 Aug;54(8):2430-5.

18.

First episode of major depressive disorder and vascular factors in coronary artery disease patients: Baseline characteristics and response to antidepressant treatment in the CREATE trial.

Habra ME, Baker B, Frasure-Smith N, Swenson JR, Koszycki D, Butler G, van Zyl LT, Lespérance F.

J Psychosom Res. 2010 Aug;69(2):133-41. doi: 10.1016/j.jpsychores.2010.02.010. Epub 2010 Apr 7.

PMID:
20624511
19.

Changes in plasma and platelet BDNF levels induced by S-citalopram in major depression.

Serra-Millàs M, López-Vílchez I, Navarro V, Galán AM, Escolar G, Penadés R, Catalán R, Fañanás L, Arias B, Gastó C.

Psychopharmacology (Berl). 2011 Jul;216(1):1-8. doi: 10.1007/s00213-011-2180-0. Epub 2011 Feb 11.

PMID:
21308467
20.

Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy.

Siasos G, Oikonomou E, Zaromitidou M, Kioufis S, Kokkou E, Mourouzis K, Vlasis K, Vavuranakis M, Stone PH, Papavassiliou AG, Tousoulis D.

Atherosclerosis. 2015 Sep;242(1):102-8. doi: 10.1016/j.atherosclerosis.2015.07.009. Epub 2015 Jul 11.

PMID:
26188531

Supplemental Content

Support Center